These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20039270)

  • 1. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
    Indovina P; Acquaviva A; De Falco G; Rizzo V; Onnis A; Luzzi A; Giorgi F; Hadjistilianou T; Toti P; Tomei V; Pentimalli F; Carugi A; Giordano A
    J Cell Physiol; 2010 Apr; 223(1):143-50. PubMed ID: 20039270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
    Li X; Hui AM; Sun L; Hasegawa K; Torzilli G; Minagawa M; Takayama T; Makuuchi M
    Clin Cancer Res; 2004 Nov; 10(22):7484-9. PubMed ID: 15569978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance.
    Chen M; Chen ZQ; Cui PG; Yao X; Li YM; Li AS; Gong JQ; Cao YH
    Br J Dermatol; 2008 May; 158(5):987-93. PubMed ID: 18373711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.
    García JF; Villuendas R; Algara P; Sáez AI; Sánchez-Verde L; Martínez-Montero JC; Martínez P; Piris MA
    Lab Invest; 1999 Dec; 79(12):1453-9. PubMed ID: 10616196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RB1 and CDKN2A functional defects resulting in retinoblastoma].
    Babenko OV; Zemliakova VV; Saakian SV; Brovkina AF; Strel'nikov VV; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2002; 36(5):777-83. PubMed ID: 12391839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
    Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
    Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.
    Choy KW; Pang CP; Yu CB; Wong HL; Ng JS; Fan DS; Lo KW; Chai JT; Wang J; Fu W; Lam DS
    Hum Mutat; 2002 Nov; 20(5):408. PubMed ID: 12402348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
    Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
    Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
    Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
    Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
    Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
    Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
    J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.